Table 5.
Comparison of the study’ variables between the second and third phases of the study within each group
| Parameters | Lavender Group (Mean ± SD) | Control Group (Mean ± SD) | ||||||
|---|---|---|---|---|---|---|---|---|
| Phase II | Phase III | Change | P- value | Phase 2 | Phase 3 | Change | P-value | |
| SBP | 133.16 ± 12.20 | 130.34 ± 1.23 | -2.82 ± 0.03 | 0.031* |
137.09 ± 10.04 |
135.85 ± 1.34 |
- 1.24 ± 1.29 | 0.153 |
| DBP |
78.43 ± 6.87 |
77.98 ± 0.98 |
- 0.55 ± 0.25 |
0.132 |
77.69 ± 9.98 |
77.25 ± 0.23 |
- 0.44 ± 0.94 |
0.165 |
| HR | 69.26 ± 7.76 |
68.84 ± 0.43 |
- 0.42 ± 0.81 |
0.061 |
71.68 ± 5.67 |
70.68 ± 0.23 |
- 1.00 ± 0.58 | 0.252 |
| RR |
16.48 ± 0.78 |
16.12 ± 0.96 |
- 0.36 ± 0.12 |
0.101 |
16.82 ± 6.98 |
16.21 ± 0.36 |
- 0.61 ± 0.14 |
0.143 |
| Spo2 |
97.98% ± 1.96 |
98.23% ± 0.34 |
+ 0.25% ± 0.25 | 0.112 | 96.78% ± 0.87 |
96.99% ± 0.75 |
+ 0.21% ± 0.26 | 0.367 |
| MDAS |
5.22 ± 0.54 |
3.47 ± 0.84 |
- 1.75 ± 0.13 | 0.012* |
7.30 ± 0.98 |
6.96 ± 0.57 |
- 0.34 ± 0.21 |
0.140 |
| STAI |
70.84 ± 9.91 |
66.41 ± 0.35 | - 4.43 ± 8.60 | 0.001* |
76.02 ± 0.87 |
75.45 ± 0.85 |
- 0.57 ± 0.63 |
0.136 |
| Pain score |
80.96 ± 0.87 |
69.31 ± 0.42 |
- 11.56 ± 0.25 | 0.003* |
90.84 ± 4.76 |
89.14 ± 0.64 |
- 1.7 ± 0.37 |
0.077 |
SD Standard Deviation, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HR Heart Rate, RR Respiratory Rate, Spo2 Oxygen saturation, MDAS Modified Dental Anxiety Scale, STAI Speilberger State-Trait Anxiety Inventory, VAS Visual Analog Scale
*Significant